Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease

Giannakoulas, 2016, Pulmonary arterial hypertension in congenital heart disease: current perspectives and future challenges, Hellenic J Cardiol, 57, 218, 10.1016/j.hjc.2016.05.002 Galiè, 2016, Eur Heart J, 37, 67, 10.1093/eurheartj/ehv317 Hoeper, 2013, Definitions and diagnosis of pulmonary hypertension, J Am Coll Cardiol, 62, D42, 10.1016/j.jacc.2013.10.032 Opitz, 2016, ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment, Dtsch Med Wochenschr, 141, 1764, 10.1055/s-0042-117784 Rhodes, 2013, Pulmonary hypertension: biomarkers, Handb Exp Pharmacol, 218, 77, 10.1007/978-3-662-45805-1_4 Bienertova-Vasku, 2015, MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment, J Am Soc Hypertens, 9, 221, 10.1016/j.jash.2014.12.011 Courboulin, 2016, MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?, Curr Opin Oncol, 28, 72, 10.1097/CCO.0000000000000253 Chen, 2017, Circulating microRNAs as novel biomarkers for heart failure, Hellenic J Cardiol Courboulin, 2011, Role for miR-204 in human pulmonary arterial hypertension, J Exp Med, 208, 535, 10.1084/jem.20101812 Rabinovitch, 2012, Molecular pathogenesis of pulmonary arterial hypertension, J Clin Invest, 122, 4306, 10.1172/JCI60658 Romaine, 2016, Circulating microRNAs and hypertension–from new insights into blood pressure regulation to biomarkers of cardiovascular risk, Curr Opin Pharmacol, 27, 1, 10.1016/j.coph.2015.12.002 Kiatchoosakun, 2011, Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma, Clin Cardiol, 34, 488, 10.1002/clc.20920 Lepida, 2018, The contribution of left heart disease in COPD patients with pulmonary hypertension, Hellenic J Cardiol, 10.1016/j.hjc.2018.02.001 Stevens, 2016, Regulation and function of mir-214 in pulmonary arterial hypertension, Pulm Circ, 6, 109, 10.1086/685079 Courboulin, 2011, Role for mir-204 in human pulmonary arterial hypertension, J Exp Med, 208, 535, 10.1084/jem.20101812 Jamaluddin, 2011, MiRNAs: Roles and clinical applications in vascular disease, Expert Rev Mol Diagn, 11, 79, 10.1586/erm.10.103 Meloche, 2014, MiRNAs in PAH: Biomarker, therapeutic target or both?, Drug Discov Today, 19, 1264, 10.1016/j.drudis.2014.05.015 Ai, 2010, Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction, Biochem Biophys Res Commun, 391, 73, 10.1016/j.bbrc.2009.11.005 Wang, 2010, Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans, Eur Heart J, 31, 659, 10.1093/eurheartj/ehq013 Lawrie, 2008, Detection of elevated levels of tumour-associated micrornas in serum of patients with diffuse large b-cell lymphoma, Br J Haematol, 141, 672, 10.1111/j.1365-2141.2008.07077.x Rabinowits, 2009, Exosomal microrna: a diagnostic marker for lung cancer, Clin Lung Cancer, 10, 42, 10.3816/CLC.2009.n.006